Cite
HARVARD Citation
Gupta, M. et al. (n.d.). Effects of Trastuzumab Emtansine (T‐DM1) on QT Interval and Safety of Pertuzumab Plus T‐DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer. Clinical pharmacology in drug development. 2 (1), pp. 11-24. [Online].